LBA02-04 NOVEL WEEKLY IMMUNOTHERAPY DOSING WITH AVELUMAB TOLERATED DURING BACILLUS CALMETTE-GUERIN INDUCTION THERAPY: INITIAL RESULTS OF THE ABC TRIAL
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.